A fluorescein-tagged iron(II) cage complex was obtained in a moderate total yield using a two-step synthetic procedure starting from its propargylamine-containing clathrochelate precursor. An 11-fold decrease in fluorescence quantum yield is observed in passing from the given fluorescein-based dye to its clathrochelate derivative. An excitation energy transfer from the terminal fluorescent group of the macrobicyclic molecule to its quasiaromatic highly π-conjugated clathrochelate framework can explain this effect. The kinetics of the hydrolysis of the acetyl groups of acetylated fluorescein azide and its clathrochelate derivative in the presence of one equivalent of BSA evidenced no strong supramolecular host–guest interactions between BSA and the tested compounds. Study of a chemical stability of the deacetylated iron(II) clathrochelate suggested the formation of a supramolecular 1 : 1 BSA–clathrochelate assembly. Moreover, an addition of BSA or HSA to its solution caused the appearance of strong clathrochelate-based ICD outputs. The fluorescence emission anisotropy studies also evidenced the supramolecular binding of the fluorescein-tagged iron(II) clathrochelate to the BSA macromolecule, leading to a high increase in this type of anisotropy. Subcellular uptake of the fluorescein-tagged molecules was visualized using fluorescence microscopy and showed its distribution to be mainly in the cytosol without entering the nucleus or accumulating in any other organelle. An X-rayed crystal of the above propargylamide macrobicyclic precursor with a reactive terminal CC bond contains the clathrochelate molecules of two types, A and B. The encapsulated iron(II) ion in these molecules is situated in the center of its FeN6-coordination polyhedron, the geometry of which is intermediate between a trigonal prism (TP) and a trigonal antiprism (TAP). The Fe–N distances vary from 1.8754(6) to 1.9286(4) Å and the heights h of their distorted TP–TAP polyhedra are very similar (2.30 and 2.31 Å); their values of φ are equal to 25.3 and 26.6°. In this crystal, the molecules of types A and B participate in different types of hydrogen bonding, giving H-bonded clathrochelate tetramers through their carboxylic and amide groups, respectively; these tetramers are connected to H-bonded chains.
A new approach for performing Suzuki–Miyaura and Sonogashira reactions of iron(II) dihalogenoclathrochelates, optimizing their reaction conditions (such as temperature, solvent and a palladium-containing catalyst) and the nature of other reagents (such as arylboron components) is elaborated. These palladium-catalyzed reactions are very sensitive to the nature of the macrobicyclic substrates. The reactivity of the leaving halogen atoms correlates with their ability to undergo an oxidative addition, decreasing in the order: I > Br > Cl, and iron(II) diiodoclathrochelate underwent these C–C cross-couplings under their “classical” conditions. Phenylboronic, 4-carboxyphenylboronic and 6-ethoxy-2-naphthylboronic acids, and the diethyl ether of 4-(ethoxycarbonyl)boronic acid were tested as components of Suzuki–Miyaura reactions in DMF and in THF. The highest yields of the target products were obtained in DMF, while the highest activation was observed with sodium and potassium carbonates. The Suzuki–Miyaura reaction of a diiodoclathrochelate with 6-ethoxy-2-naphthylboronic acid gave the mono- and difunctionalized clathrochelates resulting from the tandem hydrodeiodination – C–C cross-coupling and double C–C cross-coupling reactions, respectively. Its Sonogashira reactions with trimethylsilylacetylene and acetylenecarboxylic acid in THF and in DMF were tested. This palladium-catalyzed reaction with a (CH3)3Si-containing active component gave the target products in a high total yield. The complexes obtained were characterized using elemental analysis, MALDI-TOF, UV-Vis, 1H and 13C{1H} NMR spectroscopy, and by single crystal XRD. Despite the non-equivalence of the ribbed α-dioximate fragments of their molecules, the encapsulated iron(II) ion is situated almost in the centre of its FeN6-coordination polyhedron, the geometry of which is almost intermediate between a trigonal prism and a trigonal antiprism.
Reactions of azide-alkilic cycloaddition are well known since 1893. At the same time, with the elaboration of click chemistry, the techniques of labelling biological objects, particularly by fluorescent dyes, were widely developed. The use of fluorescent labels provides the ability to visually monitor the process streamlines hardware load and reduces research time. Fluorescein is among the fluorophores mostly used for labelling of biomolecules due to its high quantum yields and good stability in biological media. However, despite of commercial availability of fluorescein derivatives functionalized for use in click reactions, methods for their synthesis are virtually absent in the literature. Therefore, we have developed a reliable and effective methodic for the synthesis of functionalized fluoresceines for the use in the click reactions. Synthesis of diacetyl N-(4-azidobutyl)-fluoresceine-5(6)-carboxamide was performed in six stages, starting form resorcinol and trimellitic acid anhydride. The diacetylated analogue was synthesized for the click modifications in the “soft” conditions, since N-(4-azidobutyl)-fluorescein-5(6)-carboxamide is poorly soluble in the classic organic solvents. Proposed synthetic protocol allows to increase the yield of the final and intermediate compounds and to optimized the procedure of their isolation and purification.
Aminoferrocene‐based prodrugs represent a promising class of redox‐active anticancer agents that can be selectively activated in oxidative cellular environments. However, activation of these systems typically relies on reactive oxygen species (ROS) and is therefore inefficient in intracellular compartments with low ROS levels, such as the cytoplasm. In this study, we explored strategies to enhance activation of organelle‐non‐biased aminoferrocene prodrugs through peroxynitrite (ONOO − ). Using a previously reported aminoferrocene–coumarin fluorogenic probe ( 11a ) and a set of aminoferrocene‐based prodrugs 13 and 20a and ROS‐insensitive controls 20b and 20c earlier developed in our group, we demonstrated that ONOO ‐ generated from the donor 3‐morpholinosydnonimine hydrochloride (SIN‐1) efficiently triggers cleavage of arylboronic acid groups and formation of the active aminoferrocenium species both in cell‐free systems and in cancer cells. Consistent with this mechanism, the anticancer activity of these previously described aminoferrocene‐based prodrugs was significantly enhanced in the presence of SIN‐1 across multiple cancer cell lines. To exploit this effect in a self‐contained system, we designed and synthesized a hybrid aminoferrocene prodrug bearing an organic nitrate ester moiety capable of releasing nitric oxide, which, upon reaction with endogenous superoxide anion radical, should form ONOO − . The resulting compound 7 and several control derivatives were prepared and characterized. Although the design was intended to promote intracellular ONOO − formation and ROS‐mediated activation, biological studies revealed that the nitrate ester functionality itself is the dominant determinant of cytotoxicity. Mechanistic investigations showed that prodrug 7 is efficiently internalized by cancer cells and induces moderate mitochondrial ROS formation but strongly increases intracellular aldehyde levels, likely via intramolecular nitrate‐mediated oxidation at the benzylic position. These findings highlight the complex interplay between redox chemistry, NO‐donor reactivity, and aminoferrocene activation pathways. Overall, this work demonstrates that peroxynitrite can efficiently activate aminoferrocene prodrugs in cytoplasmic environments and provides new insights into the design of redox‐active organometallic therapeutics.